Histocompatibility Antigen Complex of Man


The histocompatibility antigens are cell surface glycoproteins expressed on nucleated cells whose major function is to bind peptides within the cell or from outside and present them at the cell surface for inspection by T cells of the immune system. These antigens are a part of the major histocompatibility complex (MHC), which exists in most vertebrate species and whose products were originally defined as the most crucial elements controlling graft rejection. Human MHC research has revealed human leucocyte antigen (HLA) to be the most polymorphic genetic system in the mammalian genome, and this unique diversity parallels the need for diverse peptide sites within the MHC to combat a fast‐evolving range of pathogens. Clinical screening of HLA polymorphism is now an important prophylactic biomarker system for various diseases and a useful tool for development of peptide‐based vaccination approaches.

Key Concepts:

  • HLA is the most polymorphic component of the human genome. It is a part of the major histocompatibility complex that exists in many animal species.

  • The major function of HLA molecules is antigen presentation.

  • High degree of molecular diversity of classical HLA class I and class II molecules is a reflection of their direct role as antigen presenting molecules against a wide range of pathogens

  • MHC region is characterised by strong linkage disequilibrium between its loci such that conserved ancestral haplotypes can be identified.

  • There are population‐based differences in allelic distribution of MHC molecules primarily due to historical human migration patterns and varying microbial pressures in different geographical regions

  • An individual heterozygous at a particular HLA locus has an added advantage than homozygous as the two different HLA molecules can bind and present large number of peptides.

  • The function of the ubiquitous HLA class I gene products (HLA‐A, HLA‐B and HLA‐C) is to present endogenous peptides to responding CD8+ T cells, whereas the class II coded molecules (HLA‐DR, HLA‐DQ and HLA‐DP) have restricted tissue distribution and process exogenous peptides for presentation to CD4+ helper T cells

  • The antigen‐binding cleft of HLA class I molecules can bind peptides that are usually nonamers, whereas the HLA class II antigen‐binding cleft can bind longer peptides of 11–18 mers.

  • Polymorphisms in the MHC have been associated with disease susceptibility and varying rates of disease progression.

  • MHC matching is crucial in donor selection for haematopoietic stem cell and organ transplantation.

Keywords: major histocompatibility complex (MHC); heterodimeric glycoproteins; polymorphism; graft‐versus‐host disease (GVHD); MHC restriction; peptide–MHC interactions

Figure 1.

Schematic representation of the HLA complex on chromosome 6. The extent of the class I, II and III regions is marked and the major genes are marked by bars. MHC, major histocompatibility complex. Reproduced from Mehra NK and Kaur G (2003) MHC based vaccination approaches: progress and perspectives. Expert Reviews in Molecular Medicine5(07): 1–17, with permission from Cambridge University Press.

Figure 2.

Biochemical structure and three‐dimensional folding of HLA class I and II molecules. The two antigen‐binding domains in class I molecules are contributed by the heavy α chain, whereas both α and β chains contribute the same in the class II molecule.

Figure 3.

Number of HLA class I and class II antigens and alleles identified over the years (Adapted from http://www.ebi.ac.uk/imgt/hla/intro.html).



Benacerraf B and McDevitt HO (1972) Histocompatibility linked immune response genes. Science 175: 273–279.

Bjorkman PJ, Saper MA, Samraoui B et al. (1987a) Structure of the human class I histocompatibility antigen, HLA‐A2. Nature 329: 506–512.

Bjorkman PJ, Saper MA, Samraoni B et al. (1987b) The foreign antigen binding site and T‐cell recognition region of class I histocompatibility antigens. Nature 329: 512–518.

Klein J (1987) Origin of major histocompatibility complex polymorphism: the transpecies hypothesis. Human Immunology 19: 155–162.

Marsh SGE (2010) HLA nomenclature. In: Mehra NK (ed.) The HLA Complex in Biology and Medicine: A Resource Book, pp. 79–85. New Delhi, India: Jaypee Publishers.

Marsh SGE, Albert ED, Bodmer WF et al. (2010) Nomenclature for factors of the HLA system, 2010. Tissue Antigens 75: 291–455.

Mehra NK, Rajalingam R and Giphart MJ (1996) Generation of DR51 associated DQA1, DQB1 haplotypes in Asian Indians. Tissue Antigens 47: 85–89.

MHC Sequencing Consortium (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature 401: 921–923.

Monaco JJ and McDevitt HO (1986) The LMP antigens: a stable MHC‐controlled multisubunit protein system. Biochemistry 15: 416–426.

Spies T, Blank G and Bresnahan M (1989) A new cluster of genes within the human major histocompatibility complex. Science 243: 214–217.

Stern LJ, Brown JH, Jardetzky TS et al. (1994) Crystal structure of the human class II MHC protein HLA‐DR1 complexed with an influenza virus peptide. Nature 368: 215–221.

Terasaki PI (1991) Histocompatibility testing in transplantation. Archives of Pathology & Laboratory Medicine 115: 250–254.

Witt CS, Price P, Kaur G et al. (2002) The common HLA‐B8‐DR3 haplotype in Northern India is different from that found in Europe. Tissue Antigens 60: 474–480.

Zinkernagel RM and Doherty PC (1974) Restriction of in vitro T‐cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248: 701–702.

Further Reading

Abbas AK, Lichtman AK and Pober JS (1997) Cellular and Molecular Immunology. Philadelphia: WB Saunders.

Bodmer JG, Marsh SGE, Albert ED et al. (1997) Nomenclature for factors of the HLA system, 1996. Tissue Antigens 49: 297–321.

Charron D (1997) Genetic Diversity of HLA: Functional and Medical Implications, vols. I and II. Paris: EDK Publishers.

McCluskey J and Peh CA (1999) The human leucocyte antigens and clinical medicine: an overview. Reviews in Immunogenetics 1: 3–20.

McCluskey J (2010) HLA molecules of the major histocompatibility complex. In: Mehra NK (ed.) The HLA Complex in Biology and Medicine: A Resource Book, pp. 86–118. New Delhi, India: Jaypee Publishers.

Simpson E, Roopenian D and Goulmy E (1998) Much ado about minor histocompatibility antigens. Immunology Today 19: 108–112.

Tait, BD (2010) Genetic structure and functions of the major histocompatibility complex. In: Mehra NK (ed.) The HLA Complex in Biology and Medicine: A Resource Book, pp. 61–78. New Delhi, India: Jaypee Publishers.

Terasaki PI (1990) History of HLA: Ten Recollections. Los Angeles, CA: UCLA Tissue Typing Laboratory.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Mehra, Narinder K, and Kaur, Gurvinder(Dec 2010) Histocompatibility Antigen Complex of Man. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0001234.pub3]